BioXcel Therapeutics (BTAIQ) Enterprise Value: 92.28M

BioXcel Therapeutics, Inc. (BTAIQ)

0.052 +0.01 (+15.56%) USD | OTCM | Oct 02, 16:00

Enterprise Value Chart

Historical Enterprise Value Data

View and export this data back to 2018. Start Trial.

Date	Value
October 02, 2026	92.28M
October 01, 2026	92.06M
September 30, 2026	92.20M
September 29, 2026	92.18M
September 28, 2026	91.94M
September 25, 2026	91.85M
September 24, 2026	91.76M
September 23, 2026	92.06M
September 22, 2026	92.04M
September 21, 2026	92.58M
September 18, 2026	92.47M
September 17, 2026	93.00M
September 16, 2026	92.74M
September 15, 2026	92.05M
September 14, 2026	92.06M
September 11, 2026	92.25M
September 10, 2026	92.22M
September 09, 2026	92.12M
September 08, 2026	91.99M
September 04, 2026	92.96M
September 03, 2026	94.33M
September 02, 2026	94.00M
September 01, 2026	94.94M
August 31, 2026	95.75M
August 28, 2026	96.33M

Date	Value
August 27, 2026	113.15M
August 26, 2026	115.07M
August 25, 2026	113.88M
August 24, 2026	114.46M
August 21, 2026	115.81M
August 20, 2026	115.65M
August 19, 2026	116.55M
August 18, 2026	115.45M
August 17, 2026	118.51M
August 14, 2026	127.90M
August 13, 2026	126.02M
August 12, 2026	123.83M
August 11, 2026	119.82M
August 10, 2026	119.70M
August 07, 2026	118.88M
August 06, 2026	116.64M
August 05, 2026	116.96M
August 04, 2026	117.59M
August 03, 2026	117.18M
July 31, 2026	115.94M
July 30, 2026	115.47M
July 29, 2026	115.77M
July 28, 2026	117.10M
July 27, 2026	117.79M
July 24, 2026	117.18M

Enterprise Value Definition

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.

Read full definition.

Enterprise Value Range, Past 5 Years

View Enterprise Value Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Enterprise Value Benchmarks

View Enterprise Value Benchmarks